Finanzen von PAVmed Inc (PAVM)PAVMPAVmed Inc

Evaluating the bottom line, PAVmed Inc maintains a gross margin of -269.70%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -21278.79%, while the net margin is -19993.94%. These profitability ratios, combined with a Return on Equity (ROE) of -93.42%, provide a clear picture of how effectively PAVM converts its operational activities into shareholder value.

In the context of the broader market, PAVM competes directly with industry leaders such as NSPR and SNWV. With a market capitalization of $36.36M, it holds a significant position in the sector. When comparing efficiency, PAVM's gross margin of -269.70% stands against NSPR's -43.70% and SNWV's 73.65%. Such benchmarking helps identify whether PAVmed Inc is trading at a premium or discount relative to its financial performance.

PAVmed's financial performance shows a declining trend with significant net losses, including a $6.6 million loss in Q2 2026, down from $12.3 million the previous year. Gross margins are negative, with a gross margin of -269.70% in Q2 2026, indicating ongoing challenges in profitability.